摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-羟基-5-(三氟甲氧基)苯腈 | 875664-40-7

中文名称
2-羟基-5-(三氟甲氧基)苯腈
中文别名
2-羟基-5-(三氟甲氧基)苯甲腈
英文名称
2-hydroxy-5-(trifluoromethoxy)benzonitrile
英文别名
——
2-羟基-5-(三氟甲氧基)苯腈化学式
CAS
875664-40-7
化学式
C8H4F3NO2
mdl
MFCD04973781
分子量
203.12
InChiKey
GOAVRYAOBXORSY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    84-87°C
  • 沸点:
    246.9±40.0 °C(Predicted)
  • 密度:
    1.49±0.1 g/cm3(Predicted)
  • 稳定性/保质期:
    按规定使用和贮存的情况下,这些物质不会分解,并且能够避免光照引起的氧化。

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    53.2
  • 氢给体数:
    1
  • 氢受体数:
    6

安全信息

  • 危险等级:
    6.1
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险品运输编号:
    UN3439

反应信息

  • 作为反应物:
    描述:
    2-羟基-5-(三氟甲氧基)苯腈caesium carbonate 、 potassium hydroxide 作用下, 以 乙醇N,N-二甲基乙酰胺 为溶剂, 生成
    参考文献:
    名称:
    The design, synthesis, and biological evaluation of PIM kinase inhibitors
    摘要:
    A series of substituted benzofuropyrimidinones with pan-PIM activities and excellent selectivity against a panel of diverse kinases is described. Initial exploration identified aryl benzofuropyrimidinones that were potent, but had cell permeability limitation. Using X-ray crystal structures of the bound PIM-1 complexes with 3, 5m, and 6d, we were able to guide the SAR and identify the alkyl benzofuropyrimidinone (6l) with good PIM potencies, permeability, and oral exposure. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.04.025
点击查看最新优质反应信息

文献信息

  • NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP2921480B1
    公开(公告)日:2017-10-11
  • HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES
    申请人:F. Hoffmann-La Roche AG
    公开号:EP2900669B1
    公开(公告)日:2019-09-04
  • US9777005B2
    申请人:——
    公开号:US9777005B2
    公开(公告)日:2017-10-03
  • The design, synthesis, and biological evaluation of PIM kinase inhibitors
    作者:Amy Lew Tsuhako、David S. Brown、Elena S. Koltun、Naing Aay、Arlyn Arcalas、Vicky Chan、Hongwang Du、Stefan Engst、Maurizio Franzini、Adam Galan、Ping Huang、Stuart Johnston、Brian Kane、Moon H. Kim、A. Douglas Laird、Rui Lin、Lillian Mock、Iris Ngan、Michael Pack、Gordon Stott、Thomas J. Stout、Peiwen Yu、Cristiana Zaharia、Wentao Zhang、Peiwen Zhou、John M. Nuss、Patrick C. Kearney、Wei Xu
    DOI:10.1016/j.bmcl.2012.04.025
    日期:2012.6
    A series of substituted benzofuropyrimidinones with pan-PIM activities and excellent selectivity against a panel of diverse kinases is described. Initial exploration identified aryl benzofuropyrimidinones that were potent, but had cell permeability limitation. Using X-ray crystal structures of the bound PIM-1 complexes with 3, 5m, and 6d, we were able to guide the SAR and identify the alkyl benzofuropyrimidinone (6l) with good PIM potencies, permeability, and oral exposure. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多